F2R: Coagulation Factor II Thrombin Receptor
Key mediator of thrombin signaling in hemostasis, thrombosis, and inflammation
Gene Information Card
| Symbol | F2R |
|---|---|
| Full Name | Coagulation factor II (thrombin) receptor |
| Gene Type | protein-coding |
| Chromosomal Location | 5q13.3 |
| NCBI Gene ID | 2149 ncbi.nlm.nih.gov/gene/2149 |
| Ensembl ID | ENSG00000181104 |
| UniProt ID | P25116 |
| OMIM ID | 187930 |
| HGNC ID | 3537 |
| Aliases | PAR1, TR, CF2R, HTR, PAR-1, thrombin receptor |
Description
F2R encodes protease-activated receptor 1 (PAR1), a G protein-coupled receptor that is the prototypical member of the protease-activated receptor family. PAR1 is activated by thrombin-mediated cleavage of its N-terminal extracellular domain, exposing a tethered ligand that binds intramolecularly to initiate intracellular signaling. This receptor plays a central role in platelet activation, vascular endothelial function, and inflammatory responses. It is expressed in platelets, endothelial cells, smooth muscle cells, fibroblasts, and various cancer cells.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Thrombosis | Enhanced PAR1 signaling promotes platelet aggregation and thrombus formation | ClinVar, OMIM |
| Hemorrhagic disorders | Loss-of-function variants impair thrombin-mediated platelet activation | ClinVar, OMIM |
| Cancer (e.g., breast, colon, melanoma) | PAR1 overexpression and aberrant signaling promote tumor invasion and metastasis | COSMIC, NCBI |
| Inflammatory bowel disease | PAR1 activation contributes to intestinal inflammation and fibrosis | NCBI, UniProt |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Platelets | High | High |
| Lung | 31.2 | Medium |
| Heart | 22.5 | Medium |
| Brain | 8.7 | Low |
| Liver | 5.3 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 45.2 | High expression in recombinant systems |
| A549 (lung cancer) | 38.1 | Endogenous expression |
| MCF7 (breast cancer) | 22.4 | Moderate expression |
| HUVEC (endothelial) | 55.0 | High expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.200C>T (p.Pro67Leu) | Missense | Rare | Reduced receptor activation |
| c.374G>A (p.Arg125Gln) | Missense | Rare | Impaired thrombin cleavage |
| c.1013G>A (p.Arg338His) | Missense | Rare | Altered G-protein coupling |
| c.1270C>T (p.Arg424Trp) | Missense | Rare | Loss of function |
Mutation functional classification
Loss of Function (LOF)
Variants such as p.Pro67Leu and p.Arg125Gln reduce thrombin-mediated receptor activation and downstream signaling, leading to impaired platelet aggregation and bleeding tendency.
Gain of Function (GOF)
No well-characterized gain-of-function mutations are reported in F2R; however, overexpression in cancer is associated with aggressive tumor behavior.
Dominant Negative (DN)
No dominant-negative mutations have been described for F2R.
View complete mutation data:
Gene Ontology (GO)
| • G protein-coupled receptor activity | • thrombin-activated receptor activity |
| • signal transducer activity | • phospholipase C-activating G protein-coupled receptor signaling pathway |
| • blood coagulation | • platelet activation |
| • cell proliferation | • inflammatory response |
Pathways
• Thrombin signaling through PAR1 (Reactome: R-HSA-456926)
• GPCR downstream signaling (Reactome: R-HSA-388396)
• Platelet activation
• signaling and aggregation (Reactome: R-HSA-76002)
• Protease-activated receptor signaling (KEGG: hsa04611)
Protein Summary
The F2R protein (PAR1) is a 425-amino acid seven-transmembrane G protein-coupled receptor. It is synthesized as a precursor and cleaved intracellularly; the mature receptor is activated by thrombin which cleaves the N-terminal exodomain between Arg41 and Ser42, exposing a tethered ligand (SFLLRN). This ligand binds to the receptor's extracellular loops, triggering conformational changes that activate Gq, Gi, and G12/13 pathways. PAR1 is critical for hemostasis and thrombosis, and its dysregulation contributes to cancer progression and inflammatory diseases.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| F2RL1 Knockout HEK293T Cell Line | EDJ-KQ222 | Human | 2150 | Details Get a Quote |
| CSF2RB Knockout HEK293 Cell Line | EDJ-KQ456 | Human | 1439 | Details Get a Quote |
| F2R Knockout HEK293 Cell Line | EDJ-KQ793 | Human | 2149 | Details Get a Quote |
| F2RL3 Knockout HEK293 Cell Line | EDJ-KQ1286 | Human | 9002 | Details Get a Quote |
| IGF2R Knockout HEK293 Cell Line | EDJ-KQ2786 | Human | 3482 | Details Get a Quote |
| F2RL2 Knockout HEK293 Cell Line | EDJ-KQ4569 | Human | 2151 | Details Get a Quote |
| F2RL1 Knockout HEK293 Cell Line | EDJ-KQ17871 | Human | 2150 | Details Get a Quote |
| F2RL1 Knockout HCT 116 Cell Line | EDJ-KQ25963 | Human | 2150 | Details Get a Quote |
| F2R Knockout A-549 Cell Line | EDJ-KQ18282 | Human | 2149 | Details Get a Quote |
| F2R Knockout HCT 116 Cell Line | EDJ-KQ19509 | Human | 2149 | Details Get a Quote |
| F2R Knockout HeLa Cell Line | EDJ-KQ19510 | Human | 2149 | Details Get a Quote |
| IGF2R Knockout A-549 Cell Line | EDJ-KQ23707 | Human | 3482 | Details Get a Quote |
| IGF2R Knockout HCT 116 Cell Line | EDJ-KQ23708 | Human | 3482 | Details Get a Quote |
| IGF2R Knockout HeLa Cell Line | EDJ-KQ23709 | Human | 3482 | Details Get a Quote |
| F2RL1 Knockout A-549 Cell Line | EDJ-KQ27222 | Human | 2150 | Details Get a Quote |
Displaying Records 1 To 15 Of 32 Records
- 1
- 2
- Next Page »